archive-com.com » COM » O » ONCGNOSTICS.COM

Total: 361

Choose link from "Titles, links and description words view":

Or switch to "Titles and links view".
  • Fast and reliable results in cancer diagnostics: Biotech startup oncgnostics receives CE mark for cervical cancer test „GynTect“ | oncgnostics GmbH
    000 new cases and 7 000 deaths attributable to the cancer annually Currently screening for cervical cancer is mainly based on the analysis of cellular samples cytological scrape the so called Pap smear of the cervix uteri This test indicates if cellular changes are already present As an alternative the utilization of HPV tests allows to demonstrate the presence of an infection with high risk human papillomaviruses These viruses are the causative agents of cervical cancer However only a small number of HPV infections lead to cancer As a consequence additional examinations were required in order to get a safe diagnostic result Oncgnostics has now received CE IVD mark for its GynTect test for whole Europe The company will launch the product in the coming months in Germany and some further European markets Furthermore market entry is also intended for the US and selected Asian markets Decrease the number of unnecessary surgeries The new GynTect assay developed by oncgnostics GmbH allows to clarify within hours if a patient diagnosed with an abnormal Pap smear or a high risk HPV infection has a disease that already requires treatment For GynTect cells from a cervical scrape are analysed for the presence of so called epigenetic markers Detection of these markers may be indicative for the development or presence of cancer Almost every woman experiences an HPV infection once in her lifetime but only in very few cases this infection leads to cervical cancer Nevertheless cervical cancer is still the third most common cancer worldwide More than half of all cancer cases are fatal World Health Organization 2010 GynTect is a breakthrough regarding the possibility to avoid such unnecessary surgeries Professor Matthias Dürst leading expert in the field HPV and cancer head of the Department of Gynaecologic Molecular Biology University women s hospital Jena says Upon detection at early stage cervical cancer is almost always curable In contrast to other diagnostic methods used in cervical cancer screening GynTect can provide clear results which speak for or against the presence of cancer Even early stage disease may be detected by this diagnostic method thus allowing for an early and successful treatment GynTect is performed using the same cervical scrape material that is required for the currently performed screening tests GynTect offers patients with unclear Pap smear and or positive HPV test results fast and reliable clarification and helps thus avoiding unnecessary surgeries Only few HPV infections lead to cancer Women infected with HPV who don t have cancer cells detectable in the Pap smear mostly don t need any surgery They can obtain clarity with GynTect Prestigious VCs invest into the GynTect market potential Seed financing by the High Tech Gründerfonds and the STIFT Thüringen have enabled the spin off of oncgnostics from the University women s hospital Jena as well as the development of GynTect a recent Series A round now allows the market entry with the test Series A investors are besides HTGF and STIFT the bm t Beteiligungsmanagement Thüringen Sparkasse Jena

    Original URL path: http://www.oncgnostics.com/fast-and-reliable-results-in-cancer-diagnostics-biotech-startup-oncgnostics-receives-ce-mark-for-cervical-cancer-test-gyntect/?lang=en (2016-02-15)
    Open archived version from archive


  • January 2016 | oncgnostics GmbH
    of the cervical cancer triage test GynTect 20 January 2016 in Press Releases by TowerPR Jena Frickenhausen January 20 th 2016 With the start of 2016 the distribution of the cervical cancer triage test GynTect by Greiner Bio One has started For this purpose the internationally active company had closed a marketing and distribution partnership with oncgnostics GmbH who has developed and produces the GynTect test prior to Medica 2015 The CE IVD mark which GynTect received in October 2015 allows the utilization of the test in laboratories in whole Europe Read more Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner

    Original URL path: http://www.oncgnostics.com/2016/01/?lang=en (2016-02-15)
    Open archived version from archive

  • November 2015 | oncgnostics GmbH
    Events Talks Professional opinions statements Investors and partners Investors contact About oncgnostics About us Management Lab team Advisory board History Pipeline Ovarian cancer Head and neck cancer Access Contact Press Jobs News Blog Search oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement 18 November 2015 in Press Releases by Martina Schmitz Read more Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Show all Events Contact oncgnostics GmbH BioInstrumentezentrum Jena Winzerlaer Str 2 07745 Jena Germany oncgnostics

    Original URL path: http://www.oncgnostics.com/2015/11/?lang=en (2016-02-15)
    Open archived version from archive

  • September 2015 | oncgnostics GmbH
    Press Releases by TowerPR Jena Germany September 18 th 2015 A new test for use in cervical cancer screening is CE IVD marked in whole Europe with immediate effect It may quickly yield reliable test results which will allow to identify more cancer cases early and thus to yield better therapy outcome Developed by the biotech startup oncgnostics www oncgnostics com GynTect detects changes in cells of the cervix uteri that may be indicative for the development or presence of cancer In contrast to other methods available in cervical cancer screening GynTect will have the potential to decrease the high number of unnecessary cervical biopsies and surgeries Read more Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts

    Original URL path: http://www.oncgnostics.com/2015/09/?lang=en (2016-02-15)
    Open archived version from archive

  • Press Releases Archive | oncgnostics GmbH
    2016 the distribution of the cervical cancer triage test GynTect by Greiner Bio One has started For this purpose the internationally active company had closed a marketing and distribution partnership with oncgnostics GmbH who has developed and produces the GynTect test prior to Medica 2015 The CE IVD mark which GynTect received in October 2015 allows the utilization of the test in laboratories in whole Europe Read more oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement 18 November 2015 in Press Releases by Martina Schmitz Read more Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect 18 September 2015 in Press Releases by TowerPR Jena Germany September 18 th 2015 A new test for use in cervical cancer screening is CE IVD marked in whole Europe with immediate effect It may quickly yield reliable test results which will allow to identify more cancer cases early and thus to yield better therapy outcome Developed by the biotech startup oncgnostics www oncgnostics com GynTect detects changes in cells of the cervix uteri that may be indicative for the development or presence of cancer In contrast to other methods available in cervical cancer screening GynTect will have the potential to decrease the high number of unnecessary cervical biopsies and surgeries Read more Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information

    Original URL path: http://www.oncgnostics.com/category/press-releases/?lang=en (2016-02-15)
    Open archived version from archive

  • TowerPR, Autor auf oncgnostics GmbH
    Frickenhausen January 20th 2016 With the start of 2016 the distribution of the cervical cancer triage test GynTect by Greiner Bio One has started For this purpose the internationally active company had closed a marketing and distribution partnership with oncgnostics GmbH who has developed and produces the GynTect test prior to Medica 2015 Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect 18 September 2015 in Press Releases by TowerPR Jena Germany September 18th 2015 A new test for use in cervical cancer screening is CE IVD marked in whole Europe with immediate effect It may quickly yield reliable test results which will allow to identify more cancer cases early and thus to yield better therapy outcome Developed by the biotech startup oncgnostics www oncgnostics com GynTect Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of

    Original URL path: http://www.oncgnostics.com/author/towerpr/?lang=en (2016-02-15)
    Open archived version from archive

  • GynTect® test procedure | oncgnostics GmbH
    either by oncgnostics or by the diagnostic labs performing GynTect see Information for diagnostic labs You receive a result within a few days Download flyer GynTect for physicians diagnostic labs The five steps leading to the GynTect result 1 Recommend that your patient gets GynTect 2 Get a cervical sampler from your diagnostic laboratory or from oncgnostics 3 Take a cervical smear and send it to your diagnostic lab or to oncgnostics 4 GynTect is performed and You get the result 5 Discuss the result with your patient Information for patients Cervical cancer Cervical cancer diagnostics What is GynTect doing More information Contact FAQ patients Information for physicians GynTect test procedure Screening algorithm Trial data FAQ physicians Order Information for diagnostic laboratories Test principle Screening algorithm Trial data FAQ Labs Order Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical

    Original URL path: http://www.oncgnostics.com/gyntect-cervical-cancer/information-for-physicians/gyntect-test-procedure/?lang=en (2016-02-15)
    Open archived version from archive

  • Cervixcarzinom Archive | oncgnostics GmbH
    algorithm Trial data FAQ Labs Order For Investors Partners Press Events Talks Professional opinions statements Investors and partners Investors contact About oncgnostics About us Management Lab team Advisory board History Pipeline Ovarian cancer Head and neck cancer Access Contact Press Jobs News Blog Search Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Archive January 2016 November 2015 September 2015 Stay informed Enter your email address to subscribe to this blog and receive notifications of new posts by email Enter your Email Adress Our Topics GynTect Cervical cancer Information for patients Information for physicians Information for diagnostic laboratories Investors contact Recent Posts Greiner Bio One starts international marketing of the cervical cancer triage test GynTect oncgnostics and Greiner Bio One Diagnostics sign Partnership Agreement Fast and reliable results in cancer diagnostics Biotech startup oncgnostics receives CE mark for cervical cancer test GynTect Show all Events Contact oncgnostics GmbH BioInstrumentezentrum Jena Winzerlaer Str 2 07745 Jena Germany oncgnostics GmbH The oncgnostics GmbH a spin off of the University

    Original URL path: http://www.oncgnostics.com/tag/cervixcarzinom/?lang=en (2016-02-15)
    Open archived version from archive



  •